In Cx3cr1–/– mice, whose microglia showed enhanced inflammatory responses, we found evidence of IL-1β expression by GFAP+ astrocytes with a corresponding decrease in their overall GFAP immunoreactivity area at 20 weeks of diabetes [19]. This evidence concerns the gene GFAP and diabetes mellitus.